British International Investment's integrity is under fire following reports that millions of pounds of UK health aid have gone to corrupt and irresponsible healthcare companies. According to BII, this agency is responsible for investing funds to help "poor and marginalised sections of society." However, recent reports indicate an obvious breakdown in UK health aid transparency.
Investigators found that the agency steered money toward manufacturers of contaminated medicine and firms providing lavish perks to their staff. Following the recent scandals, both industry insiders and parliamentarians have urged an urgent investigation of BII's operations.
Unacceptable Risks After Involvement With Contaminated Medicine Producers
Although BII has received more than £5bn in government funding over the past ten years, its reputation has taken quite a beating in recent months. One of the most worrying instances of the agency's mismanagement involves an investment in the Indian pharmaceutical company Beta Drugs Limited, which produced medicine contaminated with bacteria. This contamination can be fatal.
Despite all these warning signs, BII's fund injected $14m into the company. Due diligence easily reveals these "red flags," according to independent global health advisor Anna Marriott. Still, it remains unclear how the UK aid agency failed to detect the warning signs before investing.
Misplaced Investments of International Aid Do Not Serve Global Development Purposes
Beyond mismanaging health risks, BII invests in ventures that contradict its mission to support the global poor. For instance, the agency holds over $20 million in equity shares in Medikabazaar - BII further fuels controversy by investing in Ekincare, a company that provides benefit packages to corporate giants like KPMG and BlackRock. A medical supplies platform is facing an ongoing corporate fraud case involving "phantom inventory" and fake transactions.
BII further fuels controversy by investing in Ekincare, a company that provides benefits packages to corporate giants such as KPMG and BlackRock. The fact that the UK international development agency invests in helping billion-dollar businesses poses the question of whether it truly cares about developing poor communities.
Public Demand for Ceasing of All Investments Until Further Investigation
There is an increasing number of reports about various controversial projects undertaken by BII, such as fossil fuel investments and support for hospitals known for human rights violations. As such, Sarah Champion, an MP and the chair of the International Development Committee, said that transparency needs to be BII's key priority.
As the UK government plans to cut the international aid budget to 0.3% of gross national income, it must ensure the money reaches its intended recipients. The Independent Commission for Aid Impact (ICAI) spokesperson confirmed the need to reassure the public that their contributions go towards alleviating poverty rather than aiding wrongdoers.